Page 1

Summary of Financial Statements for the Six - month Period Ended September 30 , 2021 ( IFRS , Consolidated ) October 28 , 2021 Takeda Pharmaceutical Company Limited TSE Code : Representative : Contact : 4502 Stock exchange listings : URL : http://www.takeda.com Tokyo , Nagoya , Fukuoka , Sapporo Christophe Weber , President & CEO Christopher O'Reilly Telephone : + 81-3-3278-2306 Email : takeda.ir.contact@takeda.com Global Head of IR , Global Finance Scheduled date of securities report submission : November 5 , 2021 Scheduled date of dividend payment commencement : December 1 , 2021 Supplementary materials for the financial statements : Yes Presentation to explain for the financial statements : Yes 1 . ( Million JPY , rounded to the nearest million ) Consolidated Financial Results for the Six - month Period Ended September 30 , 2021 ( April 1 to September 30 , 2021 ) ( 1 ) Consolidated Operating Results ( year to date ) ( Percentage figures represent changes over the same period of the previous year ) Net profit Revenue Operating profit Profit before tax for the period ( Million JPY ) ( % ) ( Million JPY ) ( % ) ( Million JPY ) ( % ) ( Million JPY ) ( % ) Six - month Period Ended September 30 , 2021 1,794,423 12.8 345,979 60.5 284,425 126.5 183,721 112.2 Six - month Period Ended September 30 , 2020 1,590,785 ( 4.2 ) 215,588 97.7 125,561 302.9 86,589 15.7 Net profit attributable to owners of the Company ( Million JPY ) ( % ) Total comprehensive income for the period ( Million JPY ) Basic earnings Diluted earnings per share per share ( % ) ( JPY ) ( JPY ) Six - month Period Ended September 30 , 2021 183,648 112.2 270,288 319.4 117.08 116.40 Six - month Period Ended September 30 , 2020 86,548 15.8 64,443 55.45 55.13 Six - month Period Ended September 30 , 2021 Six - month Period Ended September 30 , 2020 Core Operating Profit Core EPS ( Billion JPY ) ( % ) ( JPY ) 485.7 ( 4.3 ) 214 507.6 ( 6.3 ) 221 ( 2 ) Consolidated Financial Position As of September 30 , 2021 As of March 31 , 2021 Total assets ( Million JPY ) 12,560,273 12,912,293 Total equity ( Million JPY ) 5,324,361 5,177,177 Equity attributable to owners of the Company ( Million JPY ) 5,323,935 5,173,037 Ratio of equity attributable to owners of the Company to total assets ( % ) 42.4 40.1 Equity attributable to owners of the Company per share ( JPY ) 3,384.94 3,308.93